https://doi.org/10.15252/embj.201798335
T
Tobias Abel
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
56
Papers
1.9K
Citations
24
h-index
31
i10-index
Tobias Abel is an academic researcher from Allogene Therapeutics (United States). The author has contributed to research in topics: Analytical Chemistry and Sensors & Virus-based gene therapy research & CAR-T cell therapy research. The author has an h-index of 24, co-authored 48 publications.
Papers by this author
worksDistinct <i>in vivo</i> roles of secreted <scp>APP</scp> ectodomain variants <scp>APP</scp> sα and <scp>APP</scp> sβ in regulation of spine density, synaptic plasticity, and cognition
2018 · The EMBO Journal · 82 citations
The Stalk Domain and the Glycosylation Status of the Activating Natural Killer Cell Receptor NKp30 Are Important for Ligand Binding
2012 · Journal of Biological Chemistry · 38 citations
https://doi.org/10.1074/jbc.m111.304238
Fast responsive, optical trace level ammonia sensor for environmental monitoring
2012 · Chemistry Central Journal · 34 citations
https://doi.org/10.1186/1752-153x-6-124
The Receptor Attachment Function of Measles Virus Hemagglutinin Can Be Replaced with an Autonomous Protein That Binds Her2/ <i>neu</i> While Maintaining Its Fusion-Helper Function
2013 · Journal of Virology · 26 citations
https://doi.org/10.1128/jvi.03298-12
MOG-specific CAR Tregs: a novel approach to treat multiple sclerosis
2024 · Journal of Neuroinflammation · 26 citations
https://doi.org/10.1186/s12974-024-03262-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat